Irradiation Burn: A Complete Patient Guide

Overview

An irradiation burn (also called a radiation burn or radiodermatitis) is damage to the skin and underlying tissues caused by exposure to ionizing radiation. It can result from therapeutic radiation used to treat cancer, accidental exposure to industrial or nuclear sources, or prolonged use of diagnostic devices such as fluoroscopy.

While radiation therapy is essential for many cancer patients, up to 95 % of patients receiving external‑beam radiation develop some degree of skin reaction during treatment, ranging from mild erythema to severe ulceration.^{[1] Mayo Clinic} Accidental occupational or environmental exposure is far rarer, but when it occurs, burns can be extensive and may involve deeper tissues.

Anyone who:

• undergoes curative or palliative radiation therapy,
• works with radiologic equipment (e.g., interventional cardiology, radiography),
• has been near a nuclear incident or radioactive source,
• receives extensive diagnostic imaging with high dose rates,

is at risk for an irradiation burn. The severity depends on total dose, dose rate, fractionation schedule, and individual skin sensitivity.

Symptoms

Radiation burns evolve in stages. Symptoms may appear within hours to weeks after exposure, and they can persist for months.

Acute (early) skin reactions

• Erythema (redness): resembles a sunburn, usually appears 1–2 weeks after start of therapy.
• Dry desquamation: Peeling or flaking skin without moisture.
• Moist desquamation: Oozing, weeping patches indicating loss of the epidermal barrier.
• Edema: Swelling of the treated area.
• Pain or tenderness: Varies from mild discomfort to severe burning.

Late (chronic) skin reactions

• Telangiectasia: Dilated superficial blood vessels that appear as red lines.
• Hyperpigmentation or hypopigmentation: Darkening or lightening of the skin.
• Fibrosis (tightening of skin): Can limit mobility when over joints.
• Ulceration or necrosis: Full‑thickness tissue loss, sometimes exposing bone or muscle.
• Secondary infection: Redness, increased pain, purulent drainage.

Systemic symptoms (rare, usually with high‑dose accidental exposure)

• Nausea, vomiting, and fatigue
• Fever or chills (sign of infection)
• Hair loss in the exposed area
• Blood count abnormalities

Causes and Risk Factors

Primary causes

• External‑beam radiation therapy (EBRT): Linear accelerators delivering megavoltage X‑rays or electrons.
• Radioisotope therapy: Iodine‑131, Radium‑223, or Yttrium‑90 used for thyroid cancer, bone metastases, etc.
• Interventional radiology / fluoroscopy: Prolonged exposure during cardiac catheterization or pain management procedures.
• Industrial or nuclear accidents: Exposure to contaminated material, radiation leaks.

Risk factors that increase severity

• Total dose: Burns are more common when cumulative dose exceeds 40 Gy for photon therapy.^{[2] NCCN}
• Dose per fraction: Larger single doses cause more acute injury.
• Skin type: Fair skin (Fitzpatrick I–II) is more prone to severe erythema.
• Location: Areas with thin skin (e.g., neck, groin) or over bony prominences develop worse reactions.
• Concurrent chemotherapy or targeted therapy: Agents such as 5‑FU, cetuximab, or immunotherapy can synergistically worsen skin toxicity.
• Comorbidities: Diabetes, peripheral vascular disease, or smoking impair healing.
• Improper positioning or bolus use: Incorrect bolus placement can concentrate dose.

Diagnosis

Diagnosis relies on clinical assessment, treatment history, and, when needed, adjunct tests.

Clinical evaluation

• Detailed history of radiation exposure (type, dose, fractionation, field size).
• Physical exam focusing on skin colour, texture, presence of ulceration, and surrounding tissue.
• Grading the burn using standardized scales (e.g., RTOG/EORTC, CTCAE). Grade 1‑2 corresponds to erythema/dry desquamation; Grade 3‑4 indicates moist desquamation, ulceration, or necrosis.

Imaging and laboratory tests (when indicated)

• Ultrasound or MRI: Evaluate depth of tissue injury, especially when bone or muscle involvement is suspected.
• Wound cultures: If infection is suspected (increased pain, purulent drainage).
• Complete blood count (CBC): Detect systemic effects of high‑dose exposure.
• Biopsy: Rarely required, but can rule out malignancy recurrence or differentiate from other dermatologic conditions.

Treatment Options

Treatment is multidisciplinary, emphasizing wound care, pain control, infection prevention, and, when necessary, surgical intervention.

General principles

• Maintain a moist wound environment.
• Protect the area from further friction or UV exposure.
• Address pain early to improve compliance.
• Collaborate with radiation oncologists to adjust future treatment plans if severe toxicity occurs.

Medications

• Topical steroids: Mild to moderate potency (e.g., hydrocortisone 1 %) for erythema and itching.
• Topical silver sulfadiazine or hydrocolloid dressings: For moist desquamation to reduce bacterial colonization.
• Oral analgesics: Acetaminophen, NSAIDs (if no contraindication), or short‑term opioids for severe pain.
• Systemic antibiotics: Only if there is clinical evidence of infection (purulence, fever, positive cultures).
• Growth‑factor creams (e.g., becaplermin): May accelerate epithelialization in selected cases.

Procedural interventions

• Debridement: Gentle removal of necrotic tissue; performed by a wound‑care specialist.
• Hyperbaric oxygen therapy (HBOT): Improves oxygenation of hypoxic tissue, especially for refractory ulcers.
• Surgical reconstruction: Skin grafts or flap coverage for full‑thickness defects.
• Laser therapy: Fractional CO₂ lasers can treat chronic telangiectasia and fibrosis.

Lifestyle and supportive measures

• Keep the area clean with mild soap and lukewarm water; pat dry.
• Avoid tight clothing, friction, or abrasive fabrics.
• Use non‑adhesive dressings (e.g., silicone gauze) to prevent further trauma.
• Stay hydrated and maintain a balanced diet rich in protein and vitamins A, C, and zinc to support wound healing.
• Quit smoking and limit alcohol, both of which impair tissue repair.

Living with Irradiation Burn

Managing a radiation burn is a day‑to‑day process. Below are practical tips to reduce discomfort and promote healing.

• Daily skin assessment: Look for new redness, blistering, or drainage.
• Moisturize wisely: Apply fragrance‑free, hypoallergenic emollients after cleansing; avoid petroleum‑based products under dressings unless specifically recommended.
• Protect from the sun: Use a broad‑spectrum sunscreen (SPF 30+) and wear protective clothing; UV exposure can exacerbate radiation‑induced changes.
• Schedule regular follow‑up: See your radiation oncologist or wound‑care nurse at least every 1–2 weeks during active treatment.
• Pain management plan: Keep a pain diary; talk to your provider before increasing medication doses.
• Physical therapy: For burns over joints, gentle range‑of‑motion exercises prevent stiffness and fibrosis.
• Psychological support: Chronic skin changes can affect body image; counseling or support groups are beneficial.

Prevention

Many radiation burns are preventable with proper technique and patient education.

In clinical radiation therapy

• Use modern treatment planning (IMRT, VMAT) to limit high‑dose regions.
• Apply appropriate bolus material only when needed; avoid excess thickness.
• Implement skin‑sparing techniques such as prone positioning or customized immobilization devices.
• Provide pre‑treatment skin‑care instructions (e.g., no deodorants, lotions, or shaving on the treatment field).
• Consider prophylactic topical agents (e.g., zinc oxide ointment) in high‑risk patients, based on institutional protocols.

For occupational or diagnostic exposure

• Adhere to ALARA (As Low As Reasonably Achievable) principles.
• Wear lead aprons, thyroid shields, and radiation‑attenuating gloves when appropriate.
• Monitor personal radiation dose with badges and respect exposure limits set by OSHA and the ICRP.
• Maintain distance and use shielding during fluoroscopic procedures.

Complications

If left untreated or poorly managed, irradiation burns can lead to serious sequelae.

• Chronic ulceration: May become a portal for bacterial or fungal infection.
• Osteoradionecrosis: Bone death, especially in the mandible or pelvis, requiring surgical debridement.
• Fibrosis and contracture: Limits range of motion, can necessitate reconstructive surgery.
• Secondary malignancy: Rare, but high cumulative doses increase risk of skin cancers in the irradiated field.
• Psychosocial impact: Persistent pain, disfigurement, and functional loss can lead to depression or anxiety.

When to Seek Emergency Care

---

References

1. Mayo Clinic. Radiation side effects – skin changes. 2023. mayoclinic.org
2. National Comprehensive Cancer Network. Management of Radiation Therapy–Induced Skin Toxicity. Version 2.2024.
3. American Cancer Society. Radiation Therapy Frequently Asked Questions. 2024.
4. World Health Organization. Radiation Emergencies: Planning and Response. 2022.
5. Cleveland Clinic. Radiation Burns: Causes, Treatment, and Prevention. 2023.